Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

News Release

Printer Friendly Version View printer-friendly version
Charles River Laboratories Schedules Second-Quarter 2018 Earnings Release and Conference Call

– Schedules Investor Day on August 14th

WILMINGTON, Mass.--(BUSINESS WIRE)--Jul. 11, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2018 financial results on Wednesday, August 8th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 8th, at 8:30 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.

Investor Day

Charles River will host a Meeting with Management on Tuesday, August 14th, from 8:00 a.m. to 12:30 p.m. ET. The meeting will also be webcast on the Investor Relations section of the Company’s website at ir.criver.com.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Source: Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.
Investor Relations Contact:
Todd Spencer, 781-222-6455
Corporate Vice President, Investor Relations
todd.spencer@crl.com

Stock Quote

CRL (common)
Price
$122.12
Change (%)
+ 1.70 (1.41%)
Volume
233,125
Exchange
NYSE
Data as of 07/19/18 4:00 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)